480 results on '"Ligtenberg, Marjolijn J L"'
Search Results
2. Genome sequencing as a generic diagnostic strategy for rare disease
3. Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
4. Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups
5. Genomic instability in non–breast or ovarian malignancies of individuals with germline pathogenic variants in BRCA1/2.
6. Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer
7. Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer
8. Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients
9. Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium
10. The genomic landscape of breast and non-breast cancers from individuals with germline CHEK2 deficiency.
11. External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium
12. Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
13. External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium
14. Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden
15. Deficient mismatch repair screening of advanced adenomas in the population screening program for colorectal cancer is not effective
16. Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics
17. Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer
18. Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material
19. Unraveling Neuroendocrine Gallbladder Cancer: Comprehensive Clinicopathologic and Molecular Characterization
20. Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations
21. “The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology”: letter to the Editor
22. Functional characterisation of a novel class of in-frame insertion variants of KRAS and HRAS
23. The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First?
24. Microsatellite instability in non-colorectal and non-endometrial malignancies in patients with Lynch syndrome
25. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
26. Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study
27. Opportunities for immunotherapy in microsatellite instable colorectal cancer
28. High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling
29. RAS testing in metastatic colorectal cancer: advances in Europe
30. Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect
31. Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer
32. Identification of Fusion Genes and Targets for Genetically Matched Therapies in a Large Cohort of Salivary Gland Cancer Patients
33. Massive gastric polyposis associated with a germline SMAD4 gene mutation
34. The homogeneous mutation status of a 22 gene panel justifies the use of serial sections of colorectal cancer tissue for external quality assessment
35. Gastric cancer in three relatives of a patient with a biallelic IL12RB1 mutation
36. Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups
37. Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice
38. Additional file 1 of Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium
39. NRAS-mutated melanocytic BAP1-associated intradermal tumor (MBAIT): a case report
40. More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling
41. Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer
42. Abstract PO-011: The spectrum of pathogenic germline variants in pancreatic cancer patients with multiple primary tumors
43. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers
44. EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients
45. Plasma BRAF Mutation Detection for the Diagnostic and Monitoring Trajectory of Patients with LDH-High Stage IV Melanoma
46. Guideline on the requirements of external quality assessment programs in molecular pathology
47. EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma
48. Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors
49. Mutation analysis of KRAS prior to targeted therapy in colorectal cancer: development and evaluation of quality by a European external quality assessment scheme
50. Guidance for laboratories performing molecular pathology for cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.